SUPPLEMENTAL INFORMATION AND DISCLOSURE STATEMEN

SUPPLEMENTAL INFORMATION AND
DISCLOSURE STATEMENT OF MATERIAL
CORPORATE EVENT
FOR IMMEDIATE RELEASE –

February 11, 2021

EMERALD ORGANIC PRODUCTS INC. (currently known as Carie Health Inc.)

CUSIP: 29101T103
Trading Symbol: EMOR
OTC Pink SupplementalDisclosure


On March 30, 2020, Emerald Organic Products Inc. (“EMOR”) entered into a conditional agreement
and plan of merger with and Carie Health, Inc. (“Carie Health”), a Delaware Corporation, (the “Conditional
Merger Agreement”). Pursuant to the Conditional Merger Agreement, 100% of Carie Health’s outstanding
equity units were, subject to the fulfillment of certain conditions by Carie Health, to be exchanged for an
aggregate consideration of up to 24,000,000 shares of EMOR’s common stock.

The Conditional Merger Agreement was preliminarily terminated by EMOR on January 29, 2021 for
cause as per the Conditional Merger Agreement. After subsequent discussions occurred between EMOR
and Carie Health regarding whether or not certain conditions (the “Conditions”) had been fulfilled by Carie
Health pursuant to the Conditional Merger Agreement, it was determined by EMOR that the Conditions
had not been, and would not be, fulfilled by Carie Health. As such, EMOR has made the decision, in the
best interests of EMOR and its shareholders, to formally terminate the Conditional Merger Agreement as
of February 7, 2021.

During the term of the Conditional Merger Agreement, in anticipation of the Conditions being fulfilled by Carie Health, EMOR changed its name in Nevada to “Carie Health Inc.” Given EMOR’s decision to terminate the Conditional Merger Agreement for cause as a result of Carie not fulfilling the Conditions, EMOR has begun the process of rebranding under a different name.

/s/Ian Parker Chief Executive Officer